Dermatology

Treata develops and acquires best-in-class skin care solutions for unmet medical needs. Our innovative dermatology products provide efficacy, flexibility and convenience across a broad range of skin conditions. We are committed to offering healthcare professionals better products that will address their patients’ needs and enrich their practices.

Isopunerall^® (5-fluorouracil and salicylic acid) is a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead and balding scalp in immunocompetent adult patients.

Contact us for a
Product Monograph

Dykuris^® (isotretinoin) is an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne con globate and recalcitrant acne in patients 12 years of age and older. For full prescribing information, including further details about indications, contraindications, warnings and precautions, please consult the Dykuris Product Monograph. Patients and Healthcare Professionals can learn more about Dykuris ^® by visiting www.dykuris.ca

Contact us for a
Product Monograph

Enaniqa^® (eflornithine hydrochloride) is a topical cream indicated for the slowing of the growth of unwanted facial hair in women.

Contact us for a
Product Monograph

Zeitnocha™ (spinosad) Topical Suspension is a prescription product available in the United States of America with two indications:

Contact us United States Prescribing Information

For full United States Prescribing Information (USPI), including further details about indications, contraindications, warnings and precautions, please consult the Zeitnocha ™ USPI. Healthcare Professionals in the United States can learn more about Zeitnocha™ by visiting www.zeitnocha.com.

In July 2024, Treata Pharma Corporation completed the acquisition of this product.